FDA
EYESTAR™ DR Risk Analyzer is not commerically available. EYESTAR™ DR Risk Analyer and other VisionQuest Biomedical products are undergoing grant-funded clinical studies and is targeted to begin the FDA regulatory clearance/approval process in the fall of 2011. Visit the FDA for information about the clinical trial process, medical device and new drug approvals.